Login
Sign Up
Login
Sign Up
Features
Pricing
Reg.News
Contact
Login
Sign Up
Search
Providers
Companies
⨯
LIVE
Event in Progress:
Join Here
×
Search
Providers
Companies
⨯
Features
Pricing
Event Hub
Reg.News
Short Interest
Contact
All the news articles and press releases in one place.
UK Reg. News
German Reg. News
Search
Key Announcements
Results / Trading Updates
Get free RNS email alerts for@Model.CurrentFilterValue
Currently filtered for ANGLE plc
Clear Filter
Sector
Automobile Industry
Banks
Basic Materials
Building & Construction
Chemicals
Consumer Discretionary Goods
Consumer Discretionary Services
Consumer Staple Goods
Consumer Staple Services
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Finance
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Trusts, ETFs & Funds
Utilities
Market Cap
Below £20m
£20m - £100m
£100m - £300m
£300m - £1bn
£1bn - £10bn
Over £10bn
Filters »
All
UK100
UK250
UK SmallCap
UK Other
Show:
10
25
50
100
«
1
2
3
4
»
Date / Time
Source
Ticker
Company
Sector
Market Cap
Announcement
22Apr24 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - US and EU patents for innovative CellKeep™ slide
08Apr24 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Parsortix HER2 assay showcased at AACR 2024
22Mar24 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Parsortix at European breast cancer conference
22Jan24 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Potential utility in precision oncology
10Jan24 12:57
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Standard form for notification of major holdings
04Jan24 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Breakthrough clinical results
02Jan24 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Contract announcement with Eisai Inc.
11Dec23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Broker Announcement
11Dec23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Parsortix unlocks opportunities for drug discovery
05Dec23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
09Nov23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Trading and business update
09Nov23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Launch of PD-L1 test to support cancer studies
25Oct23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Supporting characterisation of CTCs in HNSCC
03Oct23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Parsortix outperforms standard for DTC harvest
29Sep23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Parsortix system showcased at ACTC conference
07Sep23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Interim Results for the period ended 30 June 2023
04Sep23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - ANGLE launch of Portrait Flex assay
15Aug23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - ANGLE notice of interim results
28Jun23 16:54
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Result of 2023 Annual General Meeting
27Jun23 12:24
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Standard form for notification of major holdings
05Jun23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - ANGLE announces senior management appointments
25May23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Pharma services contract with Artios Pharma
22May23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Board change - appointment of new Chairman
21Apr23 12:04
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - ANGLE presentation via Investor Meet Company
21Apr23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Results for the year ended 31 December 2022
19Apr23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - ANGLE announces partnership with BioView
17Apr23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - ANGLE Parsortix poster presented at AACR 2023
13Apr23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Pharma Services Contract with Crescendo Biologics
03Apr23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Notice of Preliminary Results and Webcast
10Mar23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Holding(s) in Company
09Feb23 14:44
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Director/PDMR shareholding
19Jan23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Holding(s) in Company
10Jan23 18:20
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Holding(s) in Company
05Jan23 07:01
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Business Update
12Dec22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
02Nov22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
18Oct22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - First regional distribution agreement
30Sep22 17:30
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
30Sep22 17:30
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Holding(s) in Company
29Sep22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Interim Results
28Sep22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Holding(s) in Company
20Jul22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Results of Capital Raise
14Jul22 17:24
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
29Jun22 16:35
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
22Jun22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Partnership with major United States urology group
27May22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Molecular characterisation of CTCs
25May22 12:30
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Preliminary Results
20Apr22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Update on laboratory accreditation
02Mar22 18:29
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Holding(s) in Company
18Feb22 17:13
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
21Jan22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
01Dec21 18:11
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
01Dec21 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
17Nov21 10:32
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
15Nov21 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
12Nov21 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
02Nov21 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Change of Adviser
21Oct21 17:25
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
15Oct21 17:45
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
30Sep21 16:02
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Issue of Equity
30Sep21 07:00
RNS
AGL:LON
ANGLE plc
Health
£32.6m
Angle PLC - Interim Results
«
1
2
3
4
»
Date / Time
Source
Company
% Chg
22Apr24 07:00
RNS
ANGLE plc
0.00%
Angle PLC - US and EU patents for innovative CellKeep™ slide
08Apr24 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Parsortix HER2 assay showcased at AACR 2024
22Mar24 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Parsortix at European breast cancer conference
22Jan24 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Potential utility in precision oncology
10Jan24 12:57
RNS
ANGLE plc
0.00%
Angle PLC - Standard form for notification of major holdings
04Jan24 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Breakthrough clinical results
02Jan24 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Contract announcement with Eisai Inc.
11Dec23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Broker Announcement
11Dec23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Parsortix unlocks opportunities for drug discovery
05Dec23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
09Nov23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Trading and business update
09Nov23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Launch of PD-L1 test to support cancer studies
25Oct23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Supporting characterisation of CTCs in HNSCC
03Oct23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Parsortix outperforms standard for DTC harvest
29Sep23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Parsortix system showcased at ACTC conference
07Sep23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Interim Results for the period ended 30 June 2023
04Sep23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - ANGLE launch of Portrait Flex assay
15Aug23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - ANGLE notice of interim results
28Jun23 16:54
RNS
ANGLE plc
0.00%
Angle PLC - Result of 2023 Annual General Meeting
27Jun23 12:24
RNS
ANGLE plc
0.00%
Angle PLC - Standard form for notification of major holdings
05Jun23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - ANGLE announces senior management appointments
25May23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Pharma services contract with Artios Pharma
22May23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Board change - appointment of new Chairman
21Apr23 12:04
RNS
ANGLE plc
0.00%
Angle PLC - ANGLE presentation via Investor Meet Company
21Apr23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Results for the year ended 31 December 2022
19Apr23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - ANGLE announces partnership with BioView
17Apr23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - ANGLE Parsortix poster presented at AACR 2023
13Apr23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Pharma Services Contract with Crescendo Biologics
03Apr23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Notice of Preliminary Results and Webcast
10Mar23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03
RNS
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
09Feb23 14:44
RNS
ANGLE plc
0.00%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20
RNS
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
10Jan23 18:20
RNS
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
05Jan23 07:01
RNS
ANGLE plc
0.00%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Business Update
12Dec22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
02Nov22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
18Oct22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23
RNS
ANGLE plc
0.00%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - First regional distribution agreement
30Sep22 17:30
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
30Sep22 17:30
RNS
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
29Sep22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Interim Results
28Sep22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30
RNS
ANGLE plc
0.00%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33
RNS
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
20Jul22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00
RNS
ANGLE plc
0.00%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Results of Capital Raise
14Jul22 17:24
RNS
ANGLE plc
0.00%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23
RNS
ANGLE plc
0.00%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
29Jun22 16:35
RNS
ANGLE plc
0.00%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
22Jun22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Partnership with major United States urology group
27May22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Molecular characterisation of CTCs
25May22 12:30
RNS
ANGLE plc
0.00%
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Preliminary Results
20Apr22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Update on laboratory accreditation
02Mar22 18:29
RNS
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
18Feb22 17:13
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
21Jan22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
01Dec21 18:11
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
01Dec21 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
17Nov21 10:32
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
15Nov21 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
12Nov21 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
02Nov21 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Change of Adviser
21Oct21 17:25
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
15Oct21 17:45
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
30Sep21 16:02
RNS
ANGLE plc
0.00%
Angle PLC - Issue of Equity
30Sep21 07:00
RNS
ANGLE plc
0.00%
Angle PLC - Interim Results
«
1
2
3
4
»
Date / Time
Company
% Chg
22Apr24 07:00
ANGLE plc
0.00%
Angle PLC - US and EU patents for innovative CellKeep™ slide
08Apr24 07:00
ANGLE plc
0.00%
Angle PLC - Parsortix HER2 assay showcased at AACR 2024
22Mar24 07:00
ANGLE plc
0.00%
Angle PLC - Parsortix at European breast cancer conference
22Jan24 07:00
ANGLE plc
0.00%
Angle PLC - Potential utility in precision oncology
10Jan24 12:57
ANGLE plc
0.00%
Angle PLC - Standard form for notification of major holdings
04Jan24 07:00
ANGLE plc
0.00%
Angle PLC - Breakthrough clinical results
02Jan24 07:00
ANGLE plc
0.00%
Angle PLC - Contract announcement with Eisai Inc.
11Dec23 07:00
ANGLE plc
0.00%
Angle PLC - Broker Announcement
11Dec23 07:00
ANGLE plc
0.00%
Angle PLC - Parsortix unlocks opportunities for drug discovery
05Dec23 07:00
ANGLE plc
0.00%
Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
09Nov23 07:00
ANGLE plc
0.00%
Angle PLC - Trading and business update
09Nov23 07:00
ANGLE plc
0.00%
Angle PLC - Launch of PD-L1 test to support cancer studies
25Oct23 07:00
ANGLE plc
0.00%
Angle PLC - Supporting characterisation of CTCs in HNSCC
03Oct23 07:00
ANGLE plc
0.00%
Angle PLC - Parsortix outperforms standard for DTC harvest
29Sep23 07:00
ANGLE plc
0.00%
Angle PLC - Parsortix system showcased at ACTC conference
07Sep23 07:00
ANGLE plc
0.00%
Angle PLC - Interim Results for the period ended 30 June 2023
04Sep23 07:00
ANGLE plc
0.00%
Angle PLC - ANGLE launch of Portrait Flex assay
15Aug23 07:00
ANGLE plc
0.00%
Angle PLC - ANGLE notice of interim results
28Jun23 16:54
ANGLE plc
0.00%
Angle PLC - Result of 2023 Annual General Meeting
27Jun23 12:24
ANGLE plc
0.00%
Angle PLC - Standard form for notification of major holdings
05Jun23 07:00
ANGLE plc
0.00%
Angle PLC - ANGLE announces senior management appointments
25May23 07:00
ANGLE plc
0.00%
Angle PLC - Pharma services contract with Artios Pharma
22May23 07:00
ANGLE plc
0.00%
Angle PLC - Board change - appointment of new Chairman
21Apr23 12:04
ANGLE plc
0.00%
Angle PLC - ANGLE presentation via Investor Meet Company
21Apr23 07:00
ANGLE plc
0.00%
Angle PLC - Results for the year ended 31 December 2022
19Apr23 07:00
ANGLE plc
0.00%
Angle PLC - ANGLE announces partnership with BioView
17Apr23 07:00
ANGLE plc
0.00%
Angle PLC - ANGLE Parsortix poster presented at AACR 2023
13Apr23 07:00
ANGLE plc
0.00%
Angle PLC - Pharma Services Contract with Crescendo Biologics
03Apr23 07:00
ANGLE plc
0.00%
Angle PLC - Notice of Preliminary Results and Webcast
10Mar23 07:00
ANGLE plc
0.00%
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
09Feb23 14:44
ANGLE plc
0.00%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00
ANGLE plc
0.00%
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
10Jan23 18:20
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
05Jan23 07:01
ANGLE plc
0.00%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00
ANGLE plc
0.00%
Angle PLC - Business Update
12Dec22 07:00
ANGLE plc
0.00%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30
ANGLE plc
0.00%
Angle PLC - Issue of Equity
02Nov22 07:00
ANGLE plc
0.00%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00
ANGLE plc
0.00%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15
ANGLE plc
0.00%
Angle PLC - Issue of Equity
18Oct22 07:00
ANGLE plc
0.00%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23
ANGLE plc
0.00%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00
ANGLE plc
0.00%
Angle PLC - First regional distribution agreement
30Sep22 17:30
ANGLE plc
0.00%
Angle PLC - Issue of Equity
30Sep22 17:30
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
29Sep22 07:00
ANGLE plc
0.00%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00
ANGLE plc
0.00%
Angle PLC - Interim Results
28Sep22 07:00
ANGLE plc
0.00%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00
ANGLE plc
0.00%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30
ANGLE plc
0.00%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00
ANGLE plc
0.00%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00
ANGLE plc
0.00%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
20Jul22 07:00
ANGLE plc
0.00%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00
ANGLE plc
0.00%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00
ANGLE plc
0.00%
Angle PLC - Results of Capital Raise
14Jul22 17:24
ANGLE plc
0.00%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23
ANGLE plc
0.00%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30
ANGLE plc
0.00%
Angle PLC - Issue of Equity
29Jun22 16:35
ANGLE plc
0.00%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00
ANGLE plc
0.00%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24
ANGLE plc
0.00%
Angle PLC - Issue of Equity
22Jun22 07:00
ANGLE plc
0.00%
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00
ANGLE plc
0.00%
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00
ANGLE plc
0.00%
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00
ANGLE plc
0.00%
Angle PLC - Partnership with major United States urology group
27May22 07:00
ANGLE plc
0.00%
Angle PLC - Molecular characterisation of CTCs
25May22 12:30
ANGLE plc
0.00%
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00
ANGLE plc
0.00%
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00
ANGLE plc
0.00%
Angle PLC - Preliminary Results
20Apr22 07:00
ANGLE plc
0.00%
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00
ANGLE plc
0.00%
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00
ANGLE plc
0.00%
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00
ANGLE plc
0.00%
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00
ANGLE plc
0.00%
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00
ANGLE plc
0.00%
Angle PLC - Update on laboratory accreditation
02Mar22 18:29
ANGLE plc
0.00%
Angle PLC - Holding(s) in Company
18Feb22 17:13
ANGLE plc
0.00%
Angle PLC - Issue of Equity
21Jan22 07:00
ANGLE plc
0.00%
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00
ANGLE plc
0.00%
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00
ANGLE plc
0.00%
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00
ANGLE plc
0.00%
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29
ANGLE plc
0.00%
Angle PLC - Issue of Equity
01Dec21 18:11
ANGLE plc
0.00%
Angle PLC - Issue of Equity
01Dec21 07:00
ANGLE plc
0.00%
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33
ANGLE plc
0.00%
Angle PLC - Issue of Equity
17Nov21 10:32
ANGLE plc
0.00%
Angle PLC - Issue of Equity
15Nov21 07:00
ANGLE plc
0.00%
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00
ANGLE plc
0.00%
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51
ANGLE plc
0.00%
Angle PLC - Issue of Equity
12Nov21 07:00
ANGLE plc
0.00%
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00
ANGLE plc
0.00%
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40
ANGLE plc
0.00%
Angle PLC - Issue of Equity
02Nov21 07:00
ANGLE plc
0.00%
Angle PLC - Change of Adviser
21Oct21 17:25
ANGLE plc
0.00%
Angle PLC - Issue of Equity
15Oct21 17:45
ANGLE plc
0.00%
Angle PLC - Issue of Equity
30Sep21 16:02
ANGLE plc
0.00%
Angle PLC - Issue of Equity
30Sep21 07:00
ANGLE plc
0.00%
Angle PLC - Interim Results
«
1
2
3
4
»
Strapline
Strapline
Question 1
Answer 1
Question 2
Answer 2
Question 3
Answer 3
Question 4
Answer 4
Question 5
Answer 5
Question 6
Answer 6
Question 7
Answer 7
Question 8
Answer 8
Top
Home
Features
Pricing
Event Hub
Reg.News
Short Interest Tracker
Explore Content
Regions
UK
Rest of EMEA
N America
APAC
LatAm
Exchanges
Aquis Apex
Australian Securities Exchange
Canadian Securities Exchange
Euronext Paris
London Stock Exchange (domestic)
SIX Swiss Exchange
Sectors
Automobile Industry
Banks
Building & Construction
Chemicals
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Utilities
Small / Large Cap
UK100
UK250
UK Smallcap
UK Other Main Markets
Other
Private/EIS
EIS Single Company
EIS/SEIS Funds
IHT Products
SEIS Single Company
VCT Funds
Providers
Free/Commissioned
ACF Equity Research
Actio Advisors
Align Research
Atrium Research
BlytheRay
BNP Paribas Exane - Sponsored Research
Brand Communications
BRR Media
Calvine Partners
Capital Access Group
Capital Markets Brokers
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Edison
Equity Development
eResearch
Fidante Partners
Five Minute Pitch TV
focusIR
Fundamental Research Corp
Galliano’s Latin Notes
goetzpartners securities Limited
H2 Radnor
Hardman & Co
Holland Advisors
Hypothesis Research
Inbound Capital
Independent Investment Research
InterAxS Global
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Magnitogorsk Iron and steel works
Mello Events
Mining Network
NuWays
Paul Scott
Peel Hunt
piworld.co.uk
Proactive
Progressive Equity Research
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Resolve Research
SEAL Advisors Ltd
ShareSoc
Shore Capital
Small Cap Consumer Research LLC
StockBox
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
Turner Pope Investments
UK Investor Group
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
High Net Worth Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
AlphaValue
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
Baptista Research
BNP Paribas Exane - Sponsored Research
Canaccord Genuity
Cavendish
Couloir Capital
Dowgate Capital
First Berlin
First Sentinel
GSBR Research
Hannam & Partners
Hybridan
Kemeny Capital
Liberum
Longspur Clean Energy
Louis Capital
Magnitogorsk Iron and steel works
Medley Global Advisors
Northland Capital Partners
QuotedData Professional
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
SP Angel
Stanford Capital Partners
Stifel FirstEnergy
Stockdale Securities
Tamesis Partners
Tennyson Securities
The Life Sciences Division
Turner Pope Investments
VSA Capital
WHIreland
Whitman Howard
Yellowstone Advisory
Zeus Capital
Institutional Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
BNP Paribas Exane
BRR Media
Calvine Partners
Canaccord Genuity
Capital Access Group
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Dowgate Capital
Edison
Equity Development
eResearch
Fidante Partners
First Berlin
First Sentinel
Five Minute Pitch TV
Fundamental Research Corp
Galliano’s Latin Notes
Goodbody
H2 Radnor
Hannam & Partners
Hardman & Co
Holland Advisors
Hybridan
Inbound Capital
Independent Investment Research
InterAxS Global
Investec Bank
Kemeny Capital
Kepler | Absolute Hedge
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Longspur Clean Energy
Magnitogorsk Iron and steel works
Mello Events
Mining Network
Northland Capital Partners
Numis
NuWays
Panmure Gordon
Peel Hunt
piworld.co.uk
Proactive
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
Small Cap Consumer Research LLC
SP Angel
Stanford Capital Partners
Stifel
StockBox
Tamesis Partners
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
UK Investor Group
Velocity Trade
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
Contact
Sign Up
Sign In
Share: